{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:08:47Z","timestamp":1785539327968,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation, Regional Science Foundation Project","award":["81960322"],"award-info":[{"award-number":["81960322"]}]},{"name":"National Natural Science Foundation, Regional Science Foundation Project","award":["82160343"],"award-info":[{"award-number":["82160343"]}]},{"name":"Joint Program of Applied Basic Research of Yunnan Provincial Department of Science and Technology - Kunming Medical University","award":["202301AY070001-106"],"award-info":[{"award-number":["202301AY070001-106"]}]},{"name":"\"Famous Doctor\" Special Project of Ten Thousand People Plan of Yunnan Province","award":["YNWR-MY-2020-095"],"award-info":[{"award-number":["YNWR-MY-2020-095"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00432-023-05135-w","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:02:11Z","timestamp":1689152531000},"page":"12379-12391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk prediction of second primary malignant tumor in primary differentiated thyroid cancer patients: a population-based study"],"prefix":"10.1007","volume":"149","author":[{"given":"Fei","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Long","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6162-5168","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-0678","authenticated-orcid":false,"given":"Zhi-Yong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"issue":"9","key":"5135_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1089\/thy.2015.0130","volume":"25","author":"A Al Afif","year":"2015","unstructured":"Al Afif A, Williams BA, Rigby MH, Bullock MJ, Taylor SM, Trites J, Hart RD (2015) Multifocal papillary thyroid cancer increases the risk of central lymph node metastasis. Thyroid 25(9):1008\u20131012. https:\/\/doi.org\/10.1089\/thy.2015.0130","journal-title":"Thyroid"},{"issue":"8","key":"5135_CR2","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1210\/en.2002-0092","volume":"144","author":"ET Alarid","year":"2003","unstructured":"Alarid ET, Preisler-Mashek MT, Solodin NM (2003) Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endocrinology 144(8):3469\u20133476. https:\/\/doi.org\/10.1210\/en.2002-0092","journal-title":"Endocrinology"},{"issue":"12","key":"5135_CR3","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1089\/thy.2014.0561","volume":"25","author":"JH An","year":"2015","unstructured":"An JH, Hwangbo Y, Ahn HY, Keam B, Lee KE, Han W, Park DJ, Park IA, Noh DY, Youn YK, Cho BY, Im SA, Park YJ (2015) A possible association between thyroid cancer and breast cancer. Thyroid 25(12):1330\u20131338. https:\/\/doi.org\/10.1089\/thy.2014.0561","journal-title":"Thyroid"},{"issue":"6","key":"5135_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.urolonc.2009.07.013","volume":"27","author":"P Bassi","year":"2009","unstructured":"Bassi P, Sacco E (2009) Cancer and aging: the molecular pathways. Urol Oncol 27(6):620\u2013627. https:\/\/doi.org\/10.1016\/j.urolonc.2009.07.013","journal-title":"Urol Oncol"},{"issue":"6","key":"5135_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.canep.2010.04.013","volume":"34","author":"MN Bassily","year":"2010","unstructured":"Bassily MN, Wilson R, Pompei F, Burmistrov D (2010) Cancer survival as a function of age at diagnosis: a study of the surveillance, epidemiology and end results database. Cancer Epidemiol 34(6):667\u2013681. https:\/\/doi.org\/10.1016\/j.canep.2010.04.013","journal-title":"Cancer Epidemiol"},{"key":"5135_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.951976","volume":"12","author":"MI Bellini","year":"2022","unstructured":"Bellini MI, Lori E, Forte F, Lauro A, Tripodi D, Amabile MI, Cantisani V, Varanese M, Ferent IC, Baldini E, Ulisse S, D\u2019Andrea V, Pironi D, Sorrenti S (2022) Thyroid and renal cancers: a bidirectional association. Front Oncol 12:951976. https:\/\/doi.org\/10.3389\/fonc.2022.951976","journal-title":"Front Oncol"},{"key":"5135_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101410","volume":"70","author":"S Borgoni","year":"2021","unstructured":"Borgoni S, Kudryashova KS, Burka K, de Magalhaes JP (2021) Targeting immune dysfunction in aging. Ageing Res Rev 70:101410. https:\/\/doi.org\/10.1016\/j.arr.2021.101410","journal-title":"Ageing Res Rev"},{"issue":"2","key":"5135_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1210\/jc.2007-1154","volume":"93","author":"AP Brown","year":"2008","unstructured":"Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD (2008) The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 93(2):504\u2013515. https:\/\/doi.org\/10.1210\/jc.2007-1154","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"5135_CR9","first-page":"4167","volume":"41","author":"MA Cerbon","year":"1981","unstructured":"Cerbon MA, Pichon MF, Milgrom E (1981) Thyroid hormone receptors in human breast cancer. Cancer Res 41(10):4167\u20134173","journal-title":"Cancer Res"},{"key":"5135_CR10","unstructured":"Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni Jr JF (eds) (2006) New malignancies among cancer survivors: SEER cancer registries, 1973\u20132000. National Cancer Institute, Bethesda. NIH Publ. No. 05-5302"},{"issue":"7","key":"5135_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/jnci\/90.7.519","volume":"90","author":"DM Dawson","year":"1998","unstructured":"Dawson DM, Lawrence EG, MacLennan GT, Amini SB, Kung HJ, Robinson D, Resnick MI, Kursh ED, Pretlow TP, Pretlow TG (1998) Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. J Natl Cancer Inst 90(7):519\u2013523. https:\/\/doi.org\/10.1093\/jnci\/90.7.519","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"5135_CR12","doi-asserted-by":"publisher","first-page":"T273","DOI":"10.1530\/ERC-14-0053","volume":"21","author":"M Derwahl","year":"2014","unstructured":"Derwahl M, Nicula D (2014) Estrogen and its role in thyroid cancer. Endocr Relat Cancer 21(5):T273\u2013T283. https:\/\/doi.org\/10.1530\/ERC-14-0053","journal-title":"Endocr Relat Cancer"},{"issue":"446","key":"5135_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. Publ Am Stat Assoc 94(446):496\u2013509","journal-title":"Publ Am Stat Assoc"},{"issue":"8","key":"5135_CR14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/thy.2016.0037","volume":"26","author":"D Hirsch","year":"2016","unstructured":"Hirsch D, Shohat T, Gorshtein A, Robenshtok E, Shimon I, Benbassat C (2016) Incidence of nonthyroidal primary malignancy and the association with(131)I treatment in patients with differentiated thyroid cancer. Thyroid 26(8):1110\u20131116. https:\/\/doi.org\/10.1089\/thy.2016.0037","journal-title":"Thyroid"},{"issue":"8","key":"5135_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/qjmed\/hcu051","volume":"107","author":"CH Hsu","year":"2014","unstructured":"Hsu CH, Huang CL, Hsu YH, Iqbal U, Nguyen PA, Jian WS (2014) Co-occurrence of second primary malignancy in patients with thyroid cancer. QJM 107(8):643\u2013648. https:\/\/doi.org\/10.1093\/qjmed\/hcu051","journal-title":"QJM"},{"key":"5135_CR16","unstructured":"Institute, National Cancer (2010) SEER cancer statistics review, 1975\u20132007 [online]. https:\/\/seer.cancer.gov\/csr\/1975_2007\/"},{"issue":"6","key":"5135_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1089\/thy.2016.0481","volume":"27","author":"E Izkhakov","year":"2017","unstructured":"Izkhakov E, Barchana M, Liphshitz I, Silverman BG, Stern N, Keinan-Boker L (2017) Trends of second primary malignancy in patients with thyroid cancer: a population-based cohort study in Israel. Thyroid 27(6):793\u2013801. https:\/\/doi.org\/10.1089\/thy.2016.0481","journal-title":"Thyroid"},{"issue":"4","key":"5135_CR18","doi-asserted-by":"publisher","first-page":"e644","DOI":"10.1634\/theoncologist.2019-0266","volume":"25","author":"H Jia","year":"2020","unstructured":"Jia H, Li Q, Yuan J, Sun X, Wu Z (2020) second primary malignancies in patients with colorectal cancer: a population-based analysis. Oncologist 25(4):e644\u2013e650. https:\/\/doi.org\/10.1634\/theoncologist.2019-0266","journal-title":"Oncologist"},{"key":"5135_CR19","unstructured":"Johnson CH, Peace S, Adamo P, Fritz A, Percy-Laurry A, Edwards BK (2007) The 2007 multiple primary and histology coding rules. National Cancer Institute, Surveillance, Epidemiology and End Results Program, Bethesda"},{"issue":"11","key":"5135_CR20","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1001\/jamaoncol.2017.0465","volume":"3","author":"THM Keegan","year":"2017","unstructured":"Keegan THM, Bleyer A, Rosenberg AS, Li Q, Goldfarb M (2017) Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors. JAMA Oncol 3(11):1554\u20131557. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0465","journal-title":"JAMA Oncol"},{"issue":"5","key":"5135_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/thy.2011.0406","volume":"23","author":"C Kim","year":"2013","unstructured":"Kim C, Bi X, Pan D, Chen Y, Carling T, Ma S, Udelsman R, Zhang Y (2013) The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23(5):575\u2013582. https:\/\/doi.org\/10.1089\/thy.2011.0406","journal-title":"Thyroid"},{"issue":"5","key":"5135_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/EJE-21-1208","volume":"186","author":"M Kim","year":"2022","unstructured":"Kim M, Kim H, Park S, Joo J, Kim IJ, Kim BH (2022a) Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study. Eur J Endocrinol 186(5):561\u2013571. https:\/\/doi.org\/10.1530\/EJE-21-1208","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"5135_CR23","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1007\/s00259-022-05779-9","volume":"49","author":"S Kim","year":"2022","unstructured":"Kim S, Bang JI, Boo D, Kim B, Choi IY, Ko S, Yoo IR, Kim K, Kim J, Joo Y, Ryoo HG, Paeng JC, Park JM, Jang W, Kim B, Chung Y, Yang D, Yoo S, Lee HY (2022b) Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics. Eur J Nucl Med Mol Imaging 49(10):3547\u20133556. https:\/\/doi.org\/10.1007\/s00259-022-05779-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5135_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad040","author":"KJ Kim","year":"2023","unstructured":"Kim KJ, Kim KJ, Choi J, Kim NH, Kim SG (2023) Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djad040","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5135_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.surg.2010.09.022","volume":"148","author":"BH Lang","year":"2010","unstructured":"Lang BH, Lo CY, Wong IO, Cowling BJ (2010) Impact of second primary malignancy on outcomes of differentiated thyroid carcinoma. Surgery 148(6):1191\u20131196. https:\/\/doi.org\/10.1016\/j.surg.2010.09.022","journal-title":"Surgery"},{"issue":"6","key":"5135_CR26","first-page":"2863","volume":"12","author":"J Li","year":"2022","unstructured":"Li J, Peng F, Huang H, Cai Z (2022) Trends in the risk of second primary malignances after non-Hodgkin\u2019s lymphoma. Am J Cancer Res 12(6):2863\u20132875","journal-title":"Am J Cancer Res"},{"key":"5135_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.7326\/0003-4819-58-1-136","volume":"58","author":"KM Lloyd 2nd","year":"1963","unstructured":"Lloyd KM 2nd, Dennis M (1963) Cowden\u2019s disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 58:136\u2013142. https:\/\/doi.org\/10.7326\/0003-4819-58-1-136","journal-title":"Ann Intern Med"},{"issue":"5","key":"5135_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1530\/EJE-13-0309","volume":"169","author":"CH Lu","year":"2013","unstructured":"Lu CH, Lee KD, Chen PT, Chen CC, Kuan FC, Huang CE, Chen MF, Chen MC (2013) Second primary malignancies following thyroid cancer: a population-based study in Taiwan. Eur J Endocrinol 169(5):577\u2013585. https:\/\/doi.org\/10.1530\/EJE-13-0309","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"5135_CR29","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1210\/jcem.85.5.6557","volume":"85","author":"CD Malchoff","year":"2000","unstructured":"Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM (2000) Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85(5):1758\u20131764. https:\/\/doi.org\/10.1210\/jcem.85.5.6557","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"5135_CR30","first-page":"1690","volume":"57","author":"YE Nikiforov","year":"1997","unstructured":"Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA (1997) Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57(9):1690\u20131694","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"5135_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0960-0760(96)00117-3","volume":"59","author":"CR Nogueira","year":"1996","unstructured":"Nogueira CR, Brentani MM (1996) Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol 59(3\u20134):271\u2013279. https:\/\/doi.org\/10.1016\/s0960-0760(96)00117-3","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"5135_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1200\/JCO.2008.18.3251","volume":"27","author":"N Nose","year":"2009","unstructured":"Nose N, Sugio K, Oyama T, Nozoe T, Uramoto H, Iwata T, Onitsuka T, Yasumoto K (2009) Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung. J Clin Oncol 27(3):411\u2013417. https:\/\/doi.org\/10.1200\/JCO.2008.18.3251","journal-title":"J Clin Oncol"},{"issue":"5\u20137","key":"5135_CR33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.steroids.2005.02.017","volume":"70","author":"RJ Pietras","year":"2005","unstructured":"Pietras RJ, Marquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M (2005) Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 70(5\u20137):372\u2013381. https:\/\/doi.org\/10.1016\/j.steroids.2005.02.017","journal-title":"Steroids"},{"issue":"4","key":"5135_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, Vaccarella S (2022) The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol 10(4):264\u2013272. https:\/\/doi.org\/10.1016\/S2213-8587(22)00035-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"5135_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijc.21064","volume":"117","author":"CM Ronckers","year":"2005","unstructured":"Ronckers CM, McCarron P, Ron E (2005) Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 117(2):281\u2013288. https:\/\/doi.org\/10.1002\/ijc.21064","journal-title":"Int J Cancer"},{"issue":"9","key":"5135_CR36","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/sj.bjc.6601319","volume":"89","author":"C Rubino","year":"2003","unstructured":"Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M (2003) Second primary malignancies in thyroid cancer patients. Br J Cancer 89(9):1638\u20131644. https:\/\/doi.org\/10.1038\/sj.bjc.6601319","journal-title":"Br J Cancer"},{"issue":"5","key":"5135_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41574-021-00470-9","volume":"17","author":"D Salvatore","year":"2021","unstructured":"Salvatore D, Santoro M, Schlumberger M (2021) The importance of the RET gene in thyroid cancer and therapeutic implications. Nat Rev Endocrinol 17(5):296\u2013306. https:\/\/doi.org\/10.1038\/s41574-021-00470-9","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"5135_CR38","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1210\/jc.2005-2009","volume":"91","author":"TC Sandeep","year":"2006","unstructured":"Sandeep TC, Strachan MW, Reynolds RM, Brewster DH, Scelo G, Pukkala E, Hemminki K, Anderson A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P (2006) Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab 91(5):1819\u20131825. https:\/\/doi.org\/10.1210\/jc.2005-2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5135_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/thy.2008.0392","volume":"19","author":"AM Sawka","year":"2009","unstructured":"Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP (2009) Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19(5):451\u2013457. https:\/\/doi.org\/10.1089\/thy.2008.0392","journal-title":"Thyroid"},{"issue":"27","key":"5135_CR40","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1038\/sj.onc.1205534","volume":"21","author":"JM Silva","year":"2002","unstructured":"Silva JM, Dominguez G, Gonzalez-Sancho JM, Garcia JM, Silva J, Garcia-Andrade C, Navarro A, Munoz A, Bonilla F (2002) Expression of thyroid hormone receptor\/erbA genes is altered in human breast cancer. Oncogene 21(27):4307\u20134316. https:\/\/doi.org\/10.1038\/sj.onc.1205534","journal-title":"Oncogene"},{"issue":"3","key":"5135_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"5135_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv314","author":"CJ Teng","year":"2016","unstructured":"Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ (2016) Use of radioactive iodine for thyroid cancer and risk of second primary malignancy: a nationwide population-based study. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv314","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"5135_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","volume":"10","author":"LB Travis","year":"2013","unstructured":"Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK (2013) Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol 10(5):289\u2013301. https:\/\/doi.org\/10.1038\/nrclinonc.2013.41","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"5135_CR44","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1089\/thy.2015.0116","volume":"25","author":"S Vaccarella","year":"2015","unstructured":"Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi S (2015) The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 25(10):1127\u20131136. https:\/\/doi.org\/10.1089\/thy.2015.0116","journal-title":"Thyroid"},{"issue":"2","key":"5135_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/cncr.29689","volume":"122","author":"W Wang","year":"2016","unstructured":"Wang W, Su X, He K, Wang Y, Wang H, Wang H, Zhao Y, Zhao W, Zarnegar R, Fahey TJ 3rd, Teng X, Teng L (2016) Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: an updated study with more than 2000 consecutive patients. Cancer 122(2):198\u2013206. https:\/\/doi.org\/10.1002\/cncr.29689","journal-title":"Cancer"},{"issue":"1","key":"5135_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","volume":"2","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J (2022) Cancer incidence and mortality in China, 2016. J Natl Cancer Center 2(1):1\u20139. https:\/\/doi.org\/10.1016\/j.jncc.2022.02.002","journal-title":"J Natl Cancer Center"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05135-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05135-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05135-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T09:22:30Z","timestamp":1693300950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05135-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["5135"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05135-w","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"4 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As the data from the SEER database are publicly available, our study was exempt from ethical committee approval. Furthermore, we declare that all methods were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have given their consent to publish the paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}